Cargando…

The predictive value of patient-reported outcomes on the impact of breast cancer treatment-related quality of life

PURPOSE: Patient-reported outcomes (PROs) have been widely used to measure breast cancer (BC) treatment outcomes. However, evidence is still limited on using routinely PROs to personalize treatment decision-making, including or not chemotherapy, targeted therapy, and radiotherapy. Using patient base...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Ke, Bellanger, Martine, Le Lann, Sophie, Robert, Marie, Frenel, Jean-Sebastien, Campone, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613969/ https://www.ncbi.nlm.nih.gov/pubmed/36313651 http://dx.doi.org/10.3389/fonc.2022.925534

Ejemplares similares

Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis
por: Curtit, Elsa, et al.
Publicado: (2023)

Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor positive HER2 negative advanced breast cancer
por: du Rusquec, Pauline, et al.
Publicado: (2020)

Clinical utility of pembrolizumab in the management of advanced solid tumors: an evidence-based review on the emerging new data
por: du Rusquec, Pauline, et al.
Publicado: (2019)

The EPICURE study: a pilot prospective cohort study of heterogeneous and massive data integration in metastatic breast cancer patients
por: Colombié, Mathilde, et al.
Publicado: (2021)

Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy
por: Augereau, Paule, et al.
Publicado: (2017)

bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses
por: Jézéquel, Pascal, et al.
Publicado: (2013)

Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer
por: Domergue, Camille, et al.
Publicado: (2022)

Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for up to Ten Years in Postmenopausal Early Breast Cancer Patients
por: Moreau-Bachelard, Camille, et al.
Publicado: (2020)

Optimizing the Retrieval of the Vital Status of Cancer Patients for Health Data Warehouses by Using Open Government Data in France
por: Lauzanne, Olivier, et al.
Publicado: (2022)

Opportunities and Obstacles to the Development of Health Data Warehouses in Hospitals in France: The Recent Experience of Comprehensive Cancer Centers
por: Bocquet, François, et al.
Publicado: (2023)

Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes
por: Billaud, Amandine, et al.
Publicado: (2021)

Health-related quality of life and patient-centred outcomes with COVID-19 vaccination in patients with breast cancer and gynaecological malignancies
por: Forster, Marie, et al.
Publicado: (2023)

Contrast-Enhanced Cone-Beam Breast CT: An Analysis of Diagnostic Value in Predicting Breast Lesion With Rim Enhancement Malignancy
por: Zhao, Xin, et al.
Publicado: (2022)

Breast Cancer Survivorship, Quality of Life, and Late Toxicities
por: Nardin, Simone, et al.
Publicado: (2020)

Editorial: Quality of Life in Breast Cancer Patients and Survivors
por: Invernizzi, Marco, et al.
Publicado: (2020)

Does breast oncoplastic surgery improve quality of life?
por: Vieira, René Aloisio da Costa, et al.
Publicado: (2023)

A Prospective Analysis of Quality of Life and Toxicity Outcomes in Treating Early Breast Cancer With Breast Conservation Therapy and Intraoperative Radiation Therapy
por: Sosin, Michael, et al.
Publicado: (2018)

Efficacy of Complementary Therapies in the Quality of Life of Breast Cancer Survivors
por: Zaidi, Sahar, et al.
Publicado: (2018)

BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival
por: Champion, Ophélie, et al.
Publicado: (2023)

Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer
por: Bellanger, Aurélie, et al.
Publicado: (2021)

Quality of life and wellbeing among breast cancer patients in Lahore, Pakistan
por: Ayub, Fiza, et al.
Publicado: (2023)

Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer
por: Li, Wan-Wan, et al.
Publicado: (2022)

Prognostic and Predictive Value of BGN in Colon Cancer Outcomes and Response to Immunotherapy
por: He, Zi-Xuan, et al.
Publicado: (2022)

A convolutional neural network model for EPID‐based non‐transit dosimetry
por: Bosco, Lucas Dal, et al.
Publicado: (2023)

Community-based participatory research to improve life quality and clinical outcomes of patients with breast cancer (DianaWeb in Umbria pilot study)
por: Villarini, Milena, et al.
Publicado: (2016)

Quality of life in patients with breast cancer with neoadjuvant chemotherapy: a systematic review
por: Zhao, Yueqiu, et al.
Publicado: (2022)

BCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker
por: Tessoulin, Benoît, et al.
Publicado: (2019)

Organoids Increase the Predictive Value of in vitro Cancer Chemoprevention Studies for in vivo Outcome
por: Njoroge, Rose N., et al.
Publicado: (2019)

Health-related quality of life in Asian patients with breast cancer: a systematic review
por: Ho, Peh Joo, et al.
Publicado: (2018)

Long-Term Patient Satisfaction and Quality of Life Following Breast Reconstruction Using the BREAST-Q: A Prospective Cohort Study
por: Shiraishi, Makoto, et al.
Publicado: (2022)

Baduanjin’s impact on quality of life and sleep quality in breast cancer survivors receiving aromatase inhibitor therapy: a randomized controlled trial
por: Liao, Jingwen, et al.
Publicado: (2022)

Health-related quality of life in breast cancer patients in Asia: A meta-analysis and systematic review
por: Chen, Xinyu, et al.
Publicado: (2022)

Caregiver’s quality of life in advanced cancer: validation of the construct in a real-life setting of early palliative care
por: Borelli, Eleonora, et al.
Publicado: (2023)

Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes
por: Pelak, Maciej J., et al.
Publicado: (2022)

Predictive Value of Preoperative Multidetector-Row Computed Tomography for Axillary Lymph Nodes Metastasis in Patients With Breast Cancer
por: Chen, Chun-Fa, et al.
Publicado: (2019)

The Prognostic Prediction Value of Systemic Inflammation Score and the Development of a Nomogram for Patients With Surgically Treated Breast Cancer
por: Huang, Zhang-Zan, et al.
Publicado: (2020)

Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer
por: Tan, Qiaorui, et al.
Publicado: (2022)

Incremental value of radiomics with machine learning to the existing prognostic models for predicting outcome in renal cell carcinoma
por: Xing, Jiajun, et al.
Publicado: (2023)

Health-related quality of life measured by EQ-5D-3L for the spouses of breast cancer patients
por: Sun, Li-Fei, et al.
Publicado: (2022)

Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: A scoping review
por: Schwab, Lauren, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_chr8kkivhfo515otnkp1mrq7vp